This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Pain Control in Renal Colic

This study has been completed.
Information provided by:
Seoul National University Hospital Identifier:
First received: March 25, 2008
Last updated: September 20, 2009
Last verified: September 2009
Renal colic is very common in emergency department patients. Our aim of this study is which combination of drug is more effective in renal colic.

Condition Intervention Phase
Renal Colic Drug: buscopan Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • pain control

Study Start Date: November 2007
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
morphine, ketorolac, and buscopan
Drug: buscopan
No Intervention: 2
morphine and ketorolac


Ages Eligible for Study:   16 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • adult, clinical suspicion of renal colic

Exclusion Criteria:

  • under 15
  • do not consent
  • contraindication of morphine, ketorolac, or buscopan
  • previously pain controlled
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00646061

Korea, Republic of
Seoul National University Bundang Hospital
Seongnam-si, Kyeongi-do, Korea, Republic of, 463-707
Sponsors and Collaborators
Seoul National University Hospital
  More Information

Responsible Party: Seoul National University Hospital Identifier: NCT00646061     History of Changes
Other Study ID Numbers: B-0705/045-005
Study First Received: March 25, 2008
Last Updated: September 20, 2009

Keywords provided by Seoul National University Hospital:
renal colic

Additional relevant MeSH terms:
Renal Colic
Infant, Newborn, Diseases
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Butylscopolammonium Bromide
Scopolamine Hydrobromide
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Muscarinic Antagonists
Cholinergic Antagonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adjuvants, Anesthesia
Mydriatics processed this record on August 22, 2017